John Neylan - Chief Medical Officer, Keryx Biopharmaceuticals Inc

As of December 13, 2018


John Neylan Net Worth

  • Net worth is estimated to be at least $627.08K
  • Owns at least 148,279 units of Keryx Biopharmaceuticals Inc stock
  • Sold an estimated value of $205.12K in the last 3 years at Keryx Biopharmaceuticals Inc

John Neylan Trading

  • Largest purchase of shares was 10,000 units , worth over $62K on August 14, 2015
  • Largest sale of shares was 6,984 units , worth over $32.48K on January 31, 2017
  • In total has made about 26 transactions over 3 years
  • Usually trades in October and January, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

John Neylan Mailing Address

  • Mailing address is 750 Lexington Avenue New York NY 10022 NY

Keryx Biopharmaceuticals Inc Insider Trading

  • The most recent transaction was 111,115 units sold on December 13, 2018 by Christine Carberry worth over $33.71K
  • In the last 4 years, insiders at Keryx Biopharmaceuticals Inc sold an estimated value of $4.69M and bought an estimated value of $165.13M
  • The most active traders are Greg Madison, President and CEO,  John Neylan, Chief Medical Officer,  and Brian Adams, General Counsel and Secretary
  • Insider trading is most common in January, with the busiest year in 2018

KERYX BIOPHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1